Recent Quotes (30 days)

You have no recent quotes
chg | %

Millennium Pharmaceuticals, Inc.

Find more results for Millennium Pharmaceuticals Inc.�

Officers and directors

Deborah Dunsire
President and CEO
Mark J. Hernon


40 Landsdowne St.
Cambridge, MA 02139
+1-617-679-7000 (Phone)
617-374-7788 (Fax)

Website links

Millennium Pharmaceuticals wants to be "the" drug company for the new millennium. Operating as Millennium: The Takeda Oncology Company, it's a subsidiary of Japan's Takeda Pharmaceutical. The company's cancer drug Velcade is approved as a treatment for multiple myeloma (a blood cancer) and mantle cell lymphoma (or MCL, an aggressive form of non-Hodgkin's lymphoma). Millennium has more than a dozen other drug candidates in the pipeline, most of them cancer-related. Its oncology-focused sales force, in partnership with Johnson & Johnson, markets the drug, with Millennium handling sales in the US and various J&J subsidiaries handling sales in Europe and most other countries where Velcade is approved.

Related companies